Test is available through physicians for use with patients being evaluated for possible Alzheimer's disease or other causes of cognitive impairment
Labcorp is the first company to deliver a blood-based Amyloid-Tau-Neurodegeneration (ATN) Profile, which uses a trio of blood biomarkers to detect the hallmarks of Alzheimer's disease
Read more at prnewswire.com